Cas:10377-48-7 Lithium sulfate manufacturer & supplier

Chemical Name:Lithium sulfate

CAS.NO:10377-48-7

Synonyms:Dilithium sulfate;Lithium sulfate (2:1);UNII-919XA137JK;Sulfuric acid dilithium salt;LITHIUM SULPHATE;MFCD00011086;EINECS 233-820-4;Lithium Sulfate;dilithium,sulfate;Sulfuric acid, lithium salt (1:2)

Molecular Formula:Li₂O₄S

Molecular Weight:109.945

HS Code:

Physical and Chemical Properties:

Melting point:845 °C(lit.)

Boiling point:330ºC at 760mmHg

Density:2.22 g/mL at 25 °C(lit.)

Index of Refraction:

PSA:88.64000

Exact Mass:109.983734

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like Dilithium sulfate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sulfuric acid, lithium salt (1:2) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Lithium sulfate (2:1) Use and application,dilithium,sulfate technical grade,usp/ep/jp grade.

Related News: In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. Lithium sulfate manufacturer The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. Lithium sulfate supplier In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. Lithium sulfate vendor In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. Lithium sulfate factory China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.